RA Messages for January 15, 2002


 PHARMACY PROVIDERS,PLEASE NOTE!!!

 PLEASE MAKE THE FOLLOWING CHANGES TO THE 1/1/02 VERSION OF APPENDIX C

LABELER    COMPANY   BEGIN  END
00214 GLAXOSMITHKLINE 04/01/02   
10158 GLAXOSMITHKLINE 04/01/02   
11530 GLAXOSMITHKLINE 04/01/02   
38206 NUTRAMAX     01/01/02 
38779 MEDISCA, INC 04/01/02   
44206 ZLB BIOPLASMA, INC 04/01/02    
57480   MEDIREX, INC     01/01/02
58865 DAWN WHOLESALE PHARMA.,INC    01/01/02 
59243  SAGE PHARMACEUTICALS INC   01/01/02   
63913 MEDICAL MERCHANDISING, INC 04/01/02   
65976  ORAPHARMA  04/01/02    
74684 GLAXOSMITHKLINE 04/01/02    

  PLEASE MAKE THE FOLLOWING CHANGES TO THE 1/1/02 VERSION OF APPENDIX A

DRUG DOSAGE  STRGTH MAC EFF DATE
AMITRIPTYLINE TABLET   25MG 0.05480 01/22/02
ATENOLOL TABLET 25MG  0.06140  01/22/02  
CHLORTHALIDONE    TABLET 50MG 0.05580 01/22/02  
DEXAMETHASONE ELIXIR  0.5MG/5ML 0.03960 01/22/02
DILTIAZEM HCL  CAP.SR 24HR 240MG  OFF MAC  01/22/02
HYDROCOD BIT/HOMATROPINE SYRUP 5-1-.5MG/5 0.02800   01/22/02  
HYDROXYZINE HCL TABLET  10MG  0.05250 01/22/02 
 IS0SORBIDE DINITRATE TAB SUBL  5MG  0.04630 09/30/97
LOPERAMIDE HCL    CAPSULE  2MG 0.59300  09/30/97  
NADOLOL  TABLET 20MG  0.46500 01/22/02
NAPROXEN SODIUM TABLET  275MG  0.14890 01/22/02 
NORTRIPTYLINE HCL CAPSULE  75MG 0.22030 01/22/02 
NITROGLYCERIN  PATCH TD 24 0.2MG/HR  1.39883  09/30/97 
NITROGLYCERIN  PATCH TD 24 0.4MG/HR 1.60000  08/31/98  
NITROGLYCERIN  PATCH TD 24 0.6MG/HR OFF MAC  10/31/99 
NYSTATIN  ORAL SUSP 100MU/ML 0.00850 01/22/02  
OXAZEPAM  CAPSULE 10MG 0.53630 01/22/02
OXAZEPAM  CAPSULE 15MG 0.76240  01/22/02
PERPHENAZINE   TABLET 8MG  O.73600 09/30/97
PRAZOSIN HCL CAPSULE  1MG  0.24150  09/30/97 
PRAZOSIN HCL CAPSULE  5MG 0.57600 09/30/97 
PROPRANOLOL HCL  TABLET 20MG  0.07500 01/22/02  
PROPRANOLOL HCL  TABLET 40MG  0.05900  01/22/02  
THEOPHYLLINE ANHYDROUS  TAB/SR12H 100MG  0.09570  01/22/02 
TRIAMCINOLONE ACETONIDE CREAM 0.1%   0.04480 01/22/02  

 IF YOU ARE UNSURE ABOUT THE COVERAGE OF A DRUG PRODUCT, PLEASE CONTACT   THE PBM HELP DESK AT 1-800-648-0790.


ATTENTION MEDICAID PROVIDERS

IT HAS COME TO THE DEPARTMENT'S ATTENTION THAT SOME PROVIDERS ARE SENDING IDENTIFYING INFORMATION OVER THE INTERNET THAT MAY OR MAY NOT BE ENCRYPTED. DO NOT SEND ANY IDENTIFYING INFORMATION (E.G. NAME, SOCIAL SECURITY NUMBERS, MEDICAID NUMBERS, ETC.) OVER THE INTERNET UNLESS THIS INFORMATION IS ENCRYPTED. 


LONG TERM CARE PROVIDERS

DUE TO PROCEDURAL CHANGES, A PRIVATE CONTRACTOR, BENOVA, WILL BEGIN TAKING LONG TERM CARE APPLICATIONS EFFECTIVE JANUARY 2, 2002.  THIS WILL IN NO WAY AFFECT THE METHOD OF DETERMINING MEDICAID ELIGIBILITY FOR LONG TERM CARE APPLICANTS.

EFFECTIVE JANUARY 2, 2002, ALL REQUESTS FOR LONG TERM CARE APPLICATIONS SHOULD BE REFERRED TO BENOVA AT 1-877-456-1146 FOR PROCESSING.  INVOICES FOR PAYMENT SHOULD BE SUBMITTED BY MARCH 15, 2002.  ANY REQUESTS FOR REIMBURSEMENT MADE AFTER THIS DATE WILL NOT BE PAID.


VISION SERVICES AND EYE CARE PROGRAM PROVIDERS
CLARIFICATION OF SAME DAY/SUBSEQUENT DAY FOLLOW-UP OFFICE VISIT POLICY

A SEPARATE SAME DAY OR SUBSEQUENT DAY FOLLOW-UP OFFICE VISIT IS ALLOWED FOR THE PURPOSE OF THE DELIVERY,AND FINAL ADJUSTMENT TO THE VISUAL AXES AND ANATOMICAL TOPOGRAPHY OF MEDICAID-COVERED EYEGLASSES, CATARACT GLASSES, OR CONTACT LENSES.PRESENCE OF THE PHYSICIAN IS NOT REQUIRED.IF THE VISIT MEETS THESE CRITERIA, THE PROVIDER SHOULD BILL PROCEDURE CODE 99211. DOCUMENTATION IN THE PATIENT'S RECORD SHOULD REFLECT THAT THE PATIENT RETURNED FOR A SEPARATE VISIT ON THE SAME DAY OR SUBSEQUENT DAY FOR THE PURPOSE OF THE DELIVERY, AND FINAL ADJUSTMENT OF THE EYE WEAR, AND MUST INCLUDE A DESCRIPTION OF THE SERVICES PROVIDED. IF THE PATIENT RETURNS ON THE SAME DAY OR SUBSEQUENT DAY SIMPLY TO PICK UP THEIR EYE WEAR, AND NO FINAL ADJUSTMENTS TO THE VISUAL AXES, AND ANATOMICAL TOPOGRAPHY ARE PERFORMED, THE PROVIDER MUST NOT BILL FOR THIS SERVICE. SHOULD YOU HAVE ANY FURTHER QUESTIONS REGARDING THIS POLICY, YOU MAY CONTACT UNISYS PROVIDER RELATIONS BY CALLING 1-800-473-2783.


ATTENTION ALL MEDICAID PROVIDERS

PROVIDERS WHO WANT TO DRAW THE ATTENTION OF A REVIEWER TO A SPECIFIC PART OF A REPORT OR ATTACHMENT ARE ASKED TO CIRCLE THAT PARTICULAR PARAGRAPH OR SENTENCE.